Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9P19
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,417
Award facts
- Contract value 100% obligated
- $24,416.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,416.68 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2ml on December 12, 2025, with completion targeted for December 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. Cosentyx is a biologic medication used to treat various inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing a specialized pharmaceutical commodity within the company's broader medical supply portfolio.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a primary pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen supplies a comprehensive range of medications and medical products to support military healthcare systems and the Defense Health Agency. The company's extensive federal contracting history demonstrates its capability to fulfill complex pharmaceutical procurement requirements across multiple therapeutic domains through competitive, open-market awards.
Quick answers
Who was awarded contract SPE2DR26F9P19?
SPE2DR26F9P19 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F9P19 worth?
The government has obligated $24,417 on SPE2DR26F9P19.
Is contract SPE2DR26F9P19 an order under another contract?
Yes. SPE2DR26F9P19 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9P19 competed?
The extent of competition for SPE2DR26F9P19 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award